TECHNOLAS 217A EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P990027 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the technolas 217a excimer laser system. The device uses an optical zone treatment range from 5. 00 mm to 6. 00 mm with a blend zone of 1. 90 mm for spherical hyperopia and 1. 75 mm for hyperopic astigmatism. The laser is locked out for refractive corrections greater than +4. 00 d sphere and greater than +2. 00 d cylinder. The device is indicated for laser in-situ keratomileusis (lasik) treatments: 1) for the reduction or elimination of low-to-moderate naturally occurring hyperopia up to +4. 00 diopters (d) mrse, with sphere between +1. 00 to +4,00 d with or without refractive astigmatism up to +2. 00 d at the spectacle plane; 2) in patients who are 21 years of age or older; and, 3) in patients with documented evidence of a change in manifest refraction of less than or equal to 0. 50 diopters (in both cylinder and sphere components) for at least one year prior to the date of the pre-operative examination.

DeviceTECHNOLAS 217A EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantTECHNOLAS PERFECT VISION GMBH
Date Received2001-12-14
Decision Date2003-02-25
Notice Date2003-04-28
PMAP990027
SupplementS004
Product CodeLZS
Docket Number03M-0174
Advisory CommitteeOphthalmic
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address TECHNOLAS PERFECT VISION GMBH messerschmittstr 1 + 3 munchen 80992
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990027Original Filing
S020 2015-10-07 30-day Notice
S019 2014-01-31 30-day Notice
S018 2012-05-01 Normal 180 Day Track
S017 2012-04-26 Real-time Process
S016 2010-09-17 135 Review Track For 30-day Notice
S015 2010-06-29 Normal 180 Day Track
S014
S013 2009-10-01 Real-time Process
S012 2009-05-15 Normal 180 Day Track No User Fee
S011 2008-09-03 Normal 180 Day Track
S010 2008-08-11 Normal 180 Day Track
S009 2006-12-19 Normal 180 Day Track
S008
S007 2004-09-10 Normal 180 Day Track
S006 2002-07-18 Panel Track
S005 2002-01-31 Normal 180 Day Track
S004 2001-12-14 Panel Track
S003 2001-04-27 Normal 180 Day Track
S002 2000-11-24 Panel Track
S001 2000-10-13 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.